Don't miss

Replay


LATEST SHOWS

TALKING EUROPE

Louis Michel: 'Europe is not guilty' of Africa's failings

Read more

TALKING EUROPE

Italy's Europe minister: 'Bold measures' needed to dismantle human trafficking

Read more

ENCORE!

Music show: Blur, Martin Gore and Moriarty

Read more

FOCUS

France steps up cyber defence in wake of attacks

Read more

BUSINESS DAILY

End of an era as Volkswagen's Piech resigns

Read more

THE OBSERVERS

Police beat kids in Guinea, and militias dynamite homes in Iraq

Read more

IN THE PAPERS

Nepal vows not to be crippled by deadly quake

Read more

ENCORE!

Armenia, 100 years on

Read more

EYE ON AFRICA

Togo: Will President Faure Gnassingbe win a third 5-year term?

Read more

Americas

Obama earmarks $1.8 billion for fight against pandemic

Text by NEWS WIRES

Latest update : 2009-07-16

US President Barack Obama has designated more than $1.8 billion in emergency funds to fight a pandemic of influenza A(H1N1), or swine flu. The money will mainly go toward producing vaccines and helping plan immunisation campaigns.

REUTERS - President Barack Obama designated $1.825 billion on Thursday for emergency use to fight the new pandemic of H1N1 swine flu.

 

The money will go to buy vaccine ingredients, to help health officials plan immunization campaigns and to help get the vaccines approved at the U.S. Food and Drug Administration, Obama said in a letter to House of Representatives Speaker Nancy Pelosi.

 

"To enhance our nation's capability to respond to the potential spread of this outbreak, and in accordance with the appropriation, I hereby designate $1.825 billion of the contingent appropriation as emergency funds required to address critical needs related to emerging influenza viruses (specifically, the virus known as 2009-H1N1)," Obama wrote.

 

The money comes from $7.65 billion Congress already appropriated to the Department of Health and Human Services for the swine flu pandemic.

 

The World Health Organization said earlier on Thursday that the H1N1 flu pandemic was the fastest-moving ever and that it was now pointless to count every case.

 

WHO said at least 50 governments have placed orders for vaccines and WHO vaccine chief Marie-Paule Kieny told Reuters the potential global value of the market was estimated at between $10 billion and $20 billion.

 

 Sanofi-Aventis, Novartis, Baxter, GlaxoSmithKline, and AstraZeneca's MedImmune unit all have H1N1 vaccines for the U.S. market.

 

Date created : 2009-07-16

COMMENT(S)